Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7 » default

ClinicoEconomics and Outcomes Research


Archive: Volume 7, 2015

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir

Walker DR, Juday TR, Manthena SR, Jing Y, Sood V

ClinicoEconomics and Outcomes Research 2015, 7:637-642

Published Date: 17 December 2015

Adjustment of foreign EQ-5D-3L utilities can increase their transferability

Oddershede L, Petersen KD

ClinicoEconomics and Outcomes Research 2015, 7:629-636

Published Date: 15 December 2015

Gastrointestinal events and association with initiation of treatment for osteoporosis

Modi A, Siris ES, Tang J, Sajjan S, Sen SS

ClinicoEconomics and Outcomes Research 2015, 7:603-613

Published Date: 25 November 2015

Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Spain

Guest JF, Weidlich D, Mascuñán Díaz JI, Díaz JJ, Ojeda PM, Ferrer-González JP, Gil D, Onrubia I, Rincón Víctor P

ClinicoEconomics and Outcomes Research 2015, 7:583-591

Published Date: 23 November 2015

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs

Menditto E, Orlando V, Coretti S, Putignano D, Fiorentino D, Ruggeri M

ClinicoEconomics and Outcomes Research 2015, 7:575-581

Published Date: 11 November 2015

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats

Martyn D, Meckley LM, Miyasato G, Lim S, Riebman JB, Kocharian R, Scaife JG, Rao Y, Corral M

ClinicoEconomics and Outcomes Research 2015, 7:567-574

Published Date: 6 November 2015

The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria

Olatunya OS, Ogundare EO, Fadare JO, Oluwayemi IO, Agaja OT, Adeyefa BS, Aderiye O

ClinicoEconomics and Outcomes Research 2015, 7:545-553

Published Date: 4 November 2015

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

Grau S, Pozo JC, Romá E, Salavert M, Barrueta JA, Peral C, Rodriguez I, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2015, 7:527-535

Published Date: 13 October 2015

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan

Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M

ClinicoEconomics and Outcomes Research 2015, 7:505-520

Published Date: 7 October 2015

Estimating the health care burden of prescription opioid abuse in five European countries

Shei A, Hirst M, Kirson NY, Enloe CJ, Birnbaum HG, Dunlop WCN

ClinicoEconomics and Outcomes Research 2015, 7:477-488

Published Date: 15 September 2015

Review of the cost of venous thromboembolism

Fernandez MM, Hogue S, Preblick R, Kwong WJ

ClinicoEconomics and Outcomes Research 2015, 7:451-462

Published Date: 28 August 2015

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis

Abogunrin S, Brand S, Desai K, Dinet J, Gabriel S, Harrower T

ClinicoEconomics and Outcomes Research 2015, 7:441-449

Published Date: 9 September 2015

Impact of noncommunicable diseases in the State of Qatar

Al-Kaabi SK, Atherton A

ClinicoEconomics and Outcomes Research 2015, 7:377-385

Published Date: 2 July 2015

Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition

Wu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL

ClinicoEconomics and Outcomes Research 2015, 7:369-375

Published Date: 26 June 2015

Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan

Mandrik O, Knies S, Severens JL

ClinicoEconomics and Outcomes Research 2015, 7:347-356

Published Date: 12 June 2015

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia

Bonafede MM, Johnson BH, Richhariya A, Gandra SR

ClinicoEconomics and Outcomes Research 2015, 7:337-345

Published Date: 9 June 2015

Prevalence and cost of imaging in inpatient falls: the rising cost of falling

Fields J, Alturkistani T, Kumar N, Kanuri A, Salem DN, Munn S, Blazey-Martin D

ClinicoEconomics and Outcomes Research 2015, 7:281-286

Published Date: 3 June 2015

Adherence to statin treatment following a myocardial infarction: an Italian population-based survey

Monaldi B, Bologna G, Costa GG, D'Agostino C, Ferrante F, Filice M, Grion A, Mingarelli A, Paloscia L, Tettamanti R, Veronesi C, Degli Esposti L

ClinicoEconomics and Outcomes Research 2015, 7:273-280

Published Date: 1 June 2015

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

Tsoi B, Blackhouse G, Ferrazzi S, Reade CJ, Chen I, Goeree R

ClinicoEconomics and Outcomes Research 2015, 7:213-225

Published Date: 17 April 2015

Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis

Yang YC, Du F, Ye WY, Chen Y, Li JH, Zhang J, Nicely H, Burge R

ClinicoEconomics and Outcomes Research 2015, 7:205-212

Published Date: 13 April 2015

Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

Abogunrin S, Hortobagyi L, Remak E, Dinet J, Gabriel S, Bakheit AM

ClinicoEconomics and Outcomes Research 2015, 7:185-193

Published Date: 1 April 2015

Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study

Darbà J, Kaskens L, Detournay B, Kern W, Nicolucci A, Orozco-Beltrán D, Ramírez de Arellano A

ClinicoEconomics and Outcomes Research 2015, 7:163-171

Published Date: 23 March 2015

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update

Dal Negro RW, Bonadiman L, Turco P, Tognella S, Iannazzo S

ClinicoEconomics and Outcomes Research 2015, 7:153-159

Published Date: 16 March 2015

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

Darbà J, Kaskens L, Sorio Vilela F, Lothgren M

ClinicoEconomics and Outcomes Research 2015, 7:105-117

Published Date: 9 February 2015

Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies

McDonell AL, Kiiskinen U, Zammit DC, Kotchie RW, Thuresson PO, Nicolay C, Haslam T, Bruinsma M, Janszen-Van Oosterhout AJ, Otto T

ClinicoEconomics and Outcomes Research 2015, 7:95-103

Published Date: 30 January 2015

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece

Fragoulakis V, Vitsou E, Hernandez AC, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:85-93

Published Date: 16 January 2015

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece

Fragoulakis V, Raptis E, Vitsou E, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:73-83

Published Date: 8 January 2015

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population

Bonafede MM, Kalra VB, Miller JD, Fajardo LL

ClinicoEconomics and Outcomes Research 2015, 7:53-63

Published Date: 12 January 2015

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G

ClinicoEconomics and Outcomes Research 2015, 7:27-35

Published Date: 22 December 2014

Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context

Schinco P, Cultrera D, Valeri F, Borchiellini A, Mantuano M, Gorla F, Savarese A, Teruzzi C

ClinicoEconomics and Outcomes Research 2015, 7:17-25

Published Date: 17 December 2014

The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution?

Child DL, Cao Z, Seiberlich LE, Brown H, Greenberg J, Swanson A, Sewall MR, Robinson SB

ClinicoEconomics and Outcomes Research 2015, 7:1-8

Published Date: 15 December 2014